Peter Dowd MP: written questions
44 published records · newest first.
Written questions
Animal ExperimentsDepartment for Business, Innovation, Science and TradeTabled 15 Sept 2026Awaiting answerUIN 30003More
Question: To ask the Secretary of State for Business, Innovation, Science and Trade, what recent steps he has taken to work towards the phasing out of animal testing.
Answer: No published answer in this record yet.
Original Parliament recordLiver Diseases: Health ServicesDepartment of Health and Social CareTabled 7 Sept 2026AnsweredUIN 27483More
Question: To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce health inequalities in liver disease outcomes in the North West.
Answer: I refer the Hon. Member to the answer he received on 20 July in response to Question 17758.Subsequent to this answer, NHS England’s Transformation of Liver Services Programme has been retitled Liver Disease Programme, and has moved into the next phase of ...
Answered 15 Sept 2026
Original Parliament recordLiver Diseases: Health ServicesDepartment of Health and Social CareTabled 7 Sept 2026AnsweredUIN 27482More
Question: To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce geographic variation in liver disease (a) diagnosis (b) treatment and (c) health outcomes.
Answer: I refer the Hon. Member to the answer he received on 20 July in response to Question 17758.Subsequent to this answer, NHS England’s Transformation of Liver Services Programme has been retitled Liver Disease Programme, and has moved into the next phase of ...
Answered 15 Sept 2026
Original Parliament recordDrugs: Rare DiseasesDepartment of Health and Social CareTabled 28 Aug 2026AnsweredUIN 21169More
Question: To ask the Secretary of State for Health and Social Care, how patient organisations representing people living with rare conditions will be consulted on the development of new pilots being delivered as part of the UK-US trade agreement.
Answer: Implementation work is currently underway to develop further details for each individual pilot. Detail regarding which treatments, including for rare conditions, are included, how each pilot will function, and how stakeholders will be involved are yet to ...
Answered 15 Sept 2026
Original Parliament recordDrugs: Rare DiseasesDepartment of Health and Social CareTabled 28 Aug 2026AnsweredUIN 21168More
Question: To ask the Secretary of State for Health and Social Care, further to the UK-US pharmaceutical agreement, how the Government’s proposed pilot on productivity benefits in medicines assessment will account for the wider value of treatments for rare condition
Answer: Implementation work is currently underway to develop further details for each individual pilot. Detail regarding which treatments, including for rare conditions, are included, how each pilot will function, and how stakeholders will be involved are yet to ...
Answered 15 Sept 2026
Original Parliament recordDrugs: Rare DiseasesDepartment of Health and Social CareTabled 28 Aug 2026AnsweredUIN 21167More
Question: To ask the Secretary of State for Health and Social Care, how treatments for rare conditions will be prioritised for inclusion in the Government’s proposed pilot on supporting faster access to innovative medicines, as part of the UK-US pharmaceutical agre
Answer: Implementation work is currently underway to develop further details for each individual pilot. Detail regarding which treatments, including for rare conditions, are included, how each pilot will function, and how stakeholders will be involved are yet to ...
Answered 15 Sept 2026
Original Parliament recordSchool Meals: StandardsDepartment for EducationTabled 13 Jul 2026AnsweredUIN 18051More
Question: To ask the Secretary of State for Education, what representations her Department has received from children and young people on improving the healthiness of school food as part of the proposed updated School Food Standards.
Answer: The department knows that children and young people’s own experiences are key to shaping effective school food standards. To support this, the department has been engaging with children and young people to understand what they eat at school, what they enj...
Answered 3 Aug 2026
Original Parliament recordLiver Diseases: Health ServicesDepartment of Health and Social CareTabled 10 Jul 2026AnsweredUIN 17759More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the NHS Liver Transformation Programme reduces health inequalities in liver disease outcomes for people living in areas with high levels of deprivation.
Answer: The resource for transforming liver services sits with integrated care boards, who will consider local need and the actions to progress alongside other clinical priorities.The national team’s role has been to bring together relevant stakeholders to co-ord...
Answered 20 Jul 2026
Original Parliament recordLiver Diseases: Health ServicesDepartment of Health and Social CareTabled 10 Jul 2026AnsweredUIN 17758More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the NHS Liver Transformation Programme is adequately staffed and prioritised during the ongoing reorganisation of NHS England.
Answer: The resource for transforming liver services sits with integrated care boards, who will consider local need and the actions to progress alongside other clinical priorities.The national team’s role has been to bring together relevant stakeholders to co-ord...
Answered 20 Jul 2026
Original Parliament recordLiver Diseases: Health ServicesDepartment of Health and Social CareTabled 10 Jul 2026AnsweredUIN 17757More
Question: To ask the Secretary of State for Health and Social Care, what funding has been allocated to the NHS Liver Transformation Programme for 2026-27.
Answer: The resource for transforming liver services sits with integrated care boards, who will consider local need and the actions to progress alongside other clinical priorities.The national team’s role has been to bring together relevant stakeholders to co-ord...
Answered 20 Jul 2026
Original Parliament recordAnimal Experiments: PrimatesHome OfficeTabled 5 Jun 2026AnsweredUIN 7191More
Question: To ask the Secretary of State for the Home Department, what assessment she has made of the potential implications for her policies of the recommendations made by the Animals in Science Committee on non-human primates used in service licenses, published on
Answer: The Government welcomes the advice provided by the Animals in Science Committee (ASC) on non-human primates used in service licences and is carefully considering its recommendations to inform policy and regulatory practice. The Government will publish its...
Answered 11 Jun 2026
Original Parliament recordParking: Pedestrian AreasDepartment for TransportTabled 2 Mar 2026AnsweredUIN 116795More
Question: To ask the Secretary of State for Transport, what her Department's proposed timeline is for decriminalising pavement parking to enable local authorities to take enforcement action against vehicles parked on pavements.
Answer: On 8 January 2026, I announced the publication of the government’s formal response to the 2020 public consultation 'Pavement parking: options for change' which sets out what the government plans to do to tackle pavement parking. In the first instance we p...
Answered 5 Mar 2026
Original Parliament recordEducation and Employment: DisabilityDepartment for Work and PensionsTabled 27 Feb 2026AnsweredUIN 116515More
Question: To ask the Secretary of State for Work and Pensions, what evidence his Department holds, including survey data and commissioned research, on the extent to which disabled people identify inaccessible streets and public transport as barriers to accessing em
Answer: The Department regularly conducts research and analysis that looks at the barriers faced by disabled people such as the ‘Work aspirations and support needs of health and disability customers’ and this can be found on GOV.UK. One way the Department support...
Answered 17 Mar 2026
Original Parliament recordMultiple Sclerosis: Health ServicesDepartment of Health and Social CareTabled 9 Dec 2025AnsweredUIN 98439More
Question: To ask the Secretary of State for Health and Social Care, what data his department collects to monitor potential inequalities in multiple sclerosis care access; and how those findings are used to inform policy and service delivery improvements.
Answer: The Department does not collect patient-level clinical data directly but works with NHS England and other bodies to monitor inequalities in access to multiple sclerosis (MS) services through a range of national programmes and datasets.The UK Multiple Scle...
Answered 5 Jan 2026
Original Parliament recordCannabis: Medical TreatmentsDepartment of Health and Social CareTabled 18 Nov 2025AnsweredUIN 92020More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support and fund clinical trials aimed at achieving licensing and NHS access for complex, cannabis-based medicines used in the treatment of severe, drug-resis
Answer: The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is funding two trials to investigate the safety and efficacy of cannabinoid treatments for drug-resistant epilepsy in both adults and children...
Answered 25 Nov 2025
Original Parliament recordCannabis: Medical TreatmentsDepartment of Health and Social CareTabled 18 Nov 2025AnsweredUIN 92019More
Question: To ask the Secretary of State for Health and Social Care, whether he plans to bring responsibility for medical cannabis policy and governance to his Department in line with Schedule 2 medicines.
Answer: The Home Office is the lead department for controlled drug legislation, whilst the Department of Health and Social Care and its Arm's Length Bodies lead on healthcare and the regulation of medicines. This framework applies to all drugs under Schedules 1 t...
Answered 25 Nov 2025
Original Parliament recordRare Diseases: DrugsDepartment of Health and Social CareTabled 30 May 2025AnsweredUIN 54852More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of suspending the medicines repurposing programme on people affected by rare conditions.
Answer: In April 2025, a decision was made to suspend the national Medicines Repurposing Programme. The decision was made with consideration to the following factors: The programme team and partners have learned that there are fewer repurposing opportunities in p...
Answered 6 Jun 2025
Original Parliament recordRare DiseasesDepartment of Health and Social CareTabled 30 May 2025AnsweredUIN 54851More
Question: To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of the abolition of NHS England on people with rare conditions.
Answer: Working under the UK Rare Diseases Framework, the Government is committed to improving the lives of those living with rare diseases.We are currently in the initial phases of scoping and designing a new integrated Department that aims to enhance the effici...
Answered 19 Jun 2025
Original Parliament recordRare Diseases: Health ServicesDepartment of Health and Social CareTabled 30 May 2025AnsweredUIN 54850More
Question: To ask the Secretary of State for Health and Social Care, whether the specific challenges of providing specialised care for rare conditions will be included in the NHS 10 year plan.
Answer: The 10-Year Plan will reshape the National Health Service, and in many cases, will provide opportunities to address the challenges that are faced by patients, including those with rare conditions and the people who treat or support them.
Answered 5 Jun 2025
Original Parliament recordRare Diseases: Health ServicesDepartment of Health and Social CareTabled 30 May 2025AnsweredUIN 54849More
Question: To ask the Secretary of State for Health and Social Care, how the NHS 10 year plan will improve the delivery of healthcare for people with rare conditions.
Answer: The 10-Year Plan will reshape the National Health Service, and in many cases, will provide opportunities to address the challenges that are faced by patients, including those with rare conditions and the people who treat or support them.
Answered 5 Jun 2025
Original Parliament recordDiseasesDepartment of Health and Social CareTabled 13 May 2025AnsweredUIN 51864More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the (a) National Disease Registration Service and (b) National Congenital Anomaly and Rare Diseases Registration Service continue after the planne
Answer: Working under the UK Rare Diseases Framework, the Government is committed to improving the lives of those living with rare diseases. Digital data and technology are underpinning themes of the UK Rare Diseases Framework. We acknowledge the important role o...
Answered 19 May 2025
Original Parliament recordSpinal Muscular Atrophy: ScreeningDepartment of Health and Social CareTabled 17 Apr 2025AnsweredUIN 45629More
Question: To ask the Secretary of State for Health and Social Care, what discussions he has had with the National Institute for Health and Care Research on expediting the publication of its research brief to inform the UK National Screening Committee’s in-service e
Answer: My Rt Hon. Friend, the Secretary of State for Health and Social Care is aware of the plans being developed for the National Institute for Health and Care Research’s research call and the in-service evaluation. However, its roll out and timeline will not b...
Answered 1 May 2025
Original Parliament recordSpinal Muscular Atrophy: ScreeningDepartment of Health and Social CareTabled 17 Apr 2025AnsweredUIN 45628More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of concerns raised by the Spinal Muscular Atrophy (SMA) stakeholder community on the speed of progress being made by the UK National Screening Committee in its work to s
Answer: My Rt Hon. Friend, the Secretary of State for Health and Social Care, is aware of the concerns raised by stakeholders. Plans for the in-service evaluation are being developed; however, its roll out and timeline will not be confirmed until after the 2025 S...
Answered 2 May 2025
Original Parliament recordSpinal Muscular Atrophy: ScreeningDepartment of Health and Social CareTabled 17 Apr 2025AnsweredUIN 45627More
Question: To ask the Secretary of State for Health and Social Care, what the planned timetable is for the UK National Screening Committee's review of its advice on screening for spinal muscular atrophy.
Answer: Following the 2023 UK National Screening Committee (UK NSC) recommendation for an in-service evaluation (ISE) of spinal muscular atrophy (SMA), partnership planning between the Department, NHS England, the National Institute for Health and Care Research (...
Answered 23 Apr 2025
Original Parliament recordSpinal Muscular Atrophy: ScreeningDepartment of Health and Social CareTabled 17 Apr 2025AnsweredUIN 45626More
Question: To ask the Secretary of State for Health and Social Care, what his timetable is for releasing funds to support the UK National Screening Committee’s review of newborn screening for Spinal Muscular Atrophy.
Answer: Following the 2023 UK National Screening Committee (UK NSC) recommendation for an in-service evaluation (ISE) of spinal muscular atrophy (SMA), partnership planning between the Department, NHS England, the National Institute for Health and Care Research (...
Answered 23 Apr 2025
Original Parliament record
Published records only — not a full account of an MP’s work. How we work →